Patent details

Basic Information

Publication number:

EP3177285

PCT Application Number:

US2015043352

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP158294959

PCT Publication Number:

WO2016022446

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

[5,6]-FUSED BICYCLIC ANTIDIABETIC COMPOUNDS

French Title of Invention:

COMPOSÉS ANTIDIABÉTIQUES BICYCLIQUES À FUSION [5,6]

German Title of Invention:

[5,6]-KONDENSIERTE BICYCLISCHE ANTIDIABETISCHE VERBINDUNGEN

SPC Number:

Dates

Filing date:

03/08/2015

Grant date:

23/09/2020

EP Publication Date:

14/06/2017

PCT Publication Date:

11/02/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/09/2020

EP B1 Publication Date:

23/09/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/08/2021

Expiration date:

03/08/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/09/2020

 

 

Name:

Merck Sharp & Dohme Corp.

Address:

126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Inventor

1

Name:

PLUMMER, Christopher, W.

Address:

United States (US)

2

Name:

CHEN, Helen, Y.

Address:

United States (US)

3

Name:

FINKE, Paul, E.

Address:

United States (US)

4

Name:

DEMONG, Duane

Address:

United States (US)

Priority

Priority Number:

201462034809 P

Priority Date:

08/08/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/343; A61K 31/443; C07D 307/80; C07D 405/04; C07D 405/10;

Publication

European Patent Bulletin

Issue number:

202039

Publication date:

23/09/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages